Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03536052 · ClinicalTrials.gov registry record · NA
Ablation at Virtual-hEart pRedicted Targets for VT
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03536052: Completed NA study, sponsored by Johns Hopkins University.
NCT03536052 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03536052, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of this study is to test the efficacy of the new imaging/simulation ("virtual heart") approach for determining the optimal ablation sites in patients with VT, which render post-infarction VT non-inducible. The study will test both the acute outcome of the ablation procedure, and the effect the use of the predicted targets has upon procedure time.
Interventions
- DEVICE Virtual Heart Guided Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-09-26 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03536052
The ClinicalTrials.gov registry entry for NCT03536052 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Virtual Heart Guided Ablation is the first listed.
NCT03536052 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03536052 about?
NCT03536052 is a clinical study titled "Ablation at Virtual-hEart pRedicted Targets for VT". The goal of this study is to test the efficacy of the new imaging/simulation ("virtual heart") approach for determining the optimal ablation sites in patients with VT, which render post-infarction VT non-inducible. The study will test both the acute outcome of the ablation procedure, and the effect ...
What is the current status of trial NCT03536052?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2022-09-26. Estimated completion is 2025-12-01.
What interventions are being tested in trial NCT03536052?
The interventions under investigation include: Virtual Heart Guided Ablation (DEVICE).
Who is sponsoring clinical trial NCT03536052?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.